Marisa Taylor is a senior correspondent on the KHN enterprise team. She investigates end-of-life care and acute medical care, among other health care topics.
Marisa Taylor
From this contributor
Immigrant children detained in U.S. may struggle to get health care
By
Shefali Luthra, Marisa Taylor, Kaiser Health News
3 July 2018 | 5 min read
Thousands of children younger than 13 detained under U.S. border policy
The Trump administration has detained 2,322 children 12 years old or younger amid its border crackdown.
Thousands of children younger than 13 detained under U.S. border policy
By
Shefali Luthra, Marisa Taylor, Kaiser Health News
22 June 2018 | 6 min read
Federal limits on medical marijuana research hinder treatments
By the time Ann Marie Owen turned to marijuana to treat her pain, she was struggling to walk and talk. She also hallucinated.
Federal limits on medical marijuana research hinder treatments
By
Melissa Bailey, Marisa Taylor, Kaiser Health News
16 April 2018 | 9 min read
Trading controversy dogs health secretary nominee Tom Price
U.S. Health and Human Services secretary nominee Tom Price showed little restraint in his personal stock trading, despite the fact that a House committee he was on was under investigation.
Trading controversy dogs health secretary nominee Tom Price
By
Marisa Taylor, Christina Jewett, Kaiser Health News
9 February 2017 | 7 min read
Explore more from The Transmitter
Cracking the code of the extracellular matrix
Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.
Cracking the code of the extracellular matrix
Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.
By
Anna Victoria Molofsky
17 January 2025 | 5 min read
Huntington’s disease gene variants past a certain size poison select cells
The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.
Huntington’s disease gene variants past a certain size poison select cells
The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.
By
Angie Voyles Askham
16 January 2025 | 6 min read
X marks the spot in search for autism variants
Genetic variants on the X chromosome, including those in the gene DDX53, contribute to autism’s gender imbalance, two new studies suggest.
X marks the spot in search for autism variants
Genetic variants on the X chromosome, including those in the gene DDX53, contribute to autism’s gender imbalance, two new studies suggest.
By
Holly Barker
16 January 2025 | 6 min read